James Fetten

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma

Willi Kreis, Daniel R. Budman, James Fetten et al. · Annals of Oncology · 1999 · 157 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors

Mark H. Kaplan, Myron Susin, Savita Pahwa et al. · The American Journal of Medicine · 1987 · 141 citations

Medicine, Infectious Diseases, Oncology +13

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

Nancy Y. Lee, Eric J. Sherman, Heiko Schöder et al. · Journal of Clinical Oncology · 2024 · 93 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy

Xingzhe Li, Sarin Kitpanit, Anna Lee et al. · JAMA Network Open · 2021 · 74 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.

Steven Arkin, Francine Blei, James Fetten et al. · PubMed · 2000 · 70 citations

Medicine, Hematology, Pharmacotherapy +15